EPIGENETIC CLOCK DEVELOPMENT
$2.1M
Revenue
5
Filings
Latest Financial Summary
| Fiscal Year | Revenue | Expenses | Net Assets | Contributions |
|---|---|---|---|---|
| FY 2024 | $2.1M | $1.8M | $144K | $5K |
Key Officers
R
ROBERT BROOKE
EXECUTIVE DIRECTOR
S
STEFAN HORVATH
DIRECTOR, CHAIRMAN
D
DEAN PRISSMAN
DIRECTOR
Filing History
Similar Organizations
Medical Research · CA
INTERNATIONAL SOCIETY FOR ANTI-INFECTIVE PHARMACOLOGY
SAN LUIS OBISPO
RELATIONSHIP DEVELOPMENT RESEARCH INSTITUTE
LOS ANGELES
PARKINSON S RESEARCH CENTER INC
SN BERNRDNO
